therascreen KRAS RGQ PCR Kit
Real-time PCR assay on the Rotor-Gene Q that qualitatively detects KRAS exon 2 codon 12 and 13 mutations in FFPE colorectal tumors to support treatment decisions.
Casandra.ai provides a unified ordering experience so you can request this test directly from the performing lab, without changing your workflow.
Ordering is available where Casandra has an active integration with the performing lab. Labs that offer this test can connect with us to enable digital ordering.
About this test
The therascreen KRAS RGQ PCR Kit is an in vitro diagnostic, allele-specific real-time PCR assay that qualitatively detects KRAS exon 2 codon 12 and 13 mutations in DNA from formalin-fixed, paraffin-embedded colorectal cancer tissue. Used on the Rotor-Gene Q instrument, it reports mutation detected or not detected to establish KRAS mutation status and support targeted treatment planning.
Where this test fits
| Indication | Biomarker | Biomarker details | Therapy (Select a therapy to open its FDA-approved testing pathway) |
|---|---|---|---|
| Colorectal Cancer (CRC) | KRAS | G12A, G12D, G12R, G12C, G12S, G12V, G13D | ERBITUX, VECTIBIX |
| G12C | KRAZATI + ERBITUX, LUMAKRAS + VECTIBIX | ||
| KRAS wild-type (absence of mutations in codons 12 and 13) | ERBITUX | ||
| Non-Small Cell Lung Cancer (NSCLC) | KRAS | G12C | KRAZATI, LUMAKRAS |
IVD Manufacturer
QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and Molecular Diagnostics (clinical healthcare). As of September 30, 2025, QIAGEN employed approximately 5,700 people across more than 35 locations. For more information, visit www.qiagen.com.
Order this test
If your organization is connected to Casandra, you can place an electronic order fortherascreen KRAS RGQ PCR Kit directly from your existing workflow.
Casandra connects providers, labs, and sponsored programs so that companion diagnostics can be ordered consistently and documented cleanly, regardless of which system you start from.